Prosecution Insights
Prosecution Insights
6 pending office actions • 4 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (17%) |
| §102 only | 1 (17%) |
| §112 only | 1 (17%) |
| Double-patenting + other | 1 (17%) |
| No statute on record | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BREEN, KIMBERLY CATHERINE | 1 | 26.0% | +58.6% |
| OGUNBIYI, OLUWATOSIN A | 1 | 63.3% | +42.1% |
| DICKENS, AMELIA NICOLE | 1 | 48.2% | +22.6% |
| EDWARDS, JESSICA FAYE | 1 | 44.2% | +46.9% |
| REGLAS, GEORGIANA C | 1 | 38.8% | +30.2% |
| LYONS, MARY M | 1 | 65.5% | +41.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17673581 | COMPOSITIONS AND METHODS FOR CHARACTERIZING A MICROBIOME | LYONS, MARY M | 8d |
| 19112201 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | BREEN, KIMBERLY CATHERINE | 75d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18935074 | METHODS AND USES OF MICROBIOME COMPOSITIONS | OGUNBIYI, OLUWATOSIN A | 44d overdue |
| 18604196 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING NEURODEGENERATIVE DISEASES | DICKENS, AMELIA NICOLE | 42d overdue |
| 18073511 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING VAGUS NERVE ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | REGLAS, GEORGIANA C | 38d overdue |
| 18244685 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING EYE DISORDERS | EDWARDS, JESSICA FAYE | 5d overdue |
| 17673581 | COMPOSITIONS AND METHODS FOR CHARACTERIZING A MICROBIOME | LYONS, MARY M | 8d |
| 19112201 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | BREEN, KIMBERLY CATHERINE | 75d |
| Art Unit | Apps |
|---|---|
| 1645 | 3 |
| 1653 | 1 |
| 1657 | 1 |
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19112201 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | BREEN, KIMBERLY CATHERINE | 1653 | DPOther | Non-Final OA | 75d | Pending | Mar 14, 2025 |
| 18935074 | METHODS AND USES OF MICROBIOME COMPOSITIONS | OGUNBIYI, OLUWATOSIN A | 1645 | §102 | Non-Final OA | 44d overdue | Pending | Nov 01, 2024 |
| 18604196 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING NEURODEGENERATIVE DISEASES | DICKENS, AMELIA NICOLE | 1645 | §112 | Final Rejection | 42d overdue | Pending | Mar 13, 2024 |
| 18244685 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING EYE DISORDERS | EDWARDS, JESSICA FAYE | 1657 | Other | Non-Final OA | 5d overdue | Pending | Sep 11, 2023 |
| 18073511 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING VAGUS NERVE ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | REGLAS, GEORGIANA C | 1651 | Other | Non-Final OA | 38d overdue | Pending | Dec 01, 2022 |
| 17673581 | COMPOSITIONS AND METHODS FOR CHARACTERIZING A MICROBIOME | LYONS, MARY M | 1645 | §101 | Non-Final OA | 8d | Pending | Feb 16, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial